128 related articles for article (PubMed ID: 23796270)
1. Two cases of clear cell sarcoma with different clinical and genetic features: cutaneous type with BRAF mutation and subcutaneous type with KIT mutation.
Park BM; Jin SA; Choi YD; Shin SH; Jung ST; Lee JB; Lee SC; Yun SJ
Br J Dermatol; 2013 Dec; 169(6):1346-52. PubMed ID: 23796270
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma.
Hantschke M; Mentzel T; Rütten A; Palmedo G; Calonje E; Lazar AJ; Kutzner H
Am J Surg Pathol; 2010 Feb; 34(2):216-22. PubMed ID: 20087159
[TBL] [Abstract][Full Text] [Related]
3. Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma.
Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Geier C; Katenkamp D; Petersen I
Hum Pathol; 2012 Sep; 43(9):1463-70. PubMed ID: 22406360
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma.
Pracht M; Mogha A; Lespagnol A; Fautrel A; Mouchet N; Le Gall F; Paumier V; Lefeuvre-Plesse C; Rioux-Leclerc N; Mosser J; Oger E; Adamski H; Galibert MD; Lesimple T
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1530-8. PubMed ID: 25623140
[TBL] [Abstract][Full Text] [Related]
5. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
6. Primary clear cell sarcoma of the femur: a unique case with RT-PCR and direct sequencing confirmation of EWSR1/ATF1 fusion gene.
Kubota Y; Tanaka K; Hisaoka M; Daa T; Iwasaki T; Kawano M; Itonaga I; Tsumura H
BMC Musculoskelet Disord; 2021 Jan; 22(1):99. PubMed ID: 33478436
[TBL] [Abstract][Full Text] [Related]
7. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses).
Panagopoulos I; Mertens F; Isaksson M; Mandahl N
Cancer Genet Cytogenet; 2005 Jan; 156(1):74-6. PubMed ID: 15588860
[TBL] [Abstract][Full Text] [Related]
8. A rare case of primary dermal clear cell sarcoma with focal epidermotropism: An entity difficult to distinguish from melanoma.
Nawrocki S; Fitzhugh VA; Groisberg R; Aviv HA; Maghari A
J Cutan Pathol; 2020 Jul; 47(7):621-624. PubMed ID: 32012324
[TBL] [Abstract][Full Text] [Related]
9. Compound clear cell sarcoma misdiagnosed as a Spitz nevus.
Kiuru M; Hameed M; Busam KJ
J Cutan Pathol; 2013 Nov; 40(11):950-4. PubMed ID: 23980901
[TBL] [Abstract][Full Text] [Related]
10. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
[TBL] [Abstract][Full Text] [Related]
11. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation.
Antonescu CR; Nafa K; Segal NH; Dal Cin P; Ladanyi M
Clin Cancer Res; 2006 Sep; 12(18):5356-62. PubMed ID: 17000668
[TBL] [Abstract][Full Text] [Related]
12. Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
Schlaak M; Bajah A; Podewski T; Kreuzberg N; von Bartenwerffer W; Wardelmann E; Merkelbach-Bruse S; Büttner R; Mauch C; Kurschat P
Br J Dermatol; 2013 Apr; 168(4):708-16. PubMed ID: 23528057
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.
Antonescu CR; Tschernyavsky SJ; Woodruff JM; Jungbluth AA; Brennan MF; Ladanyi M
J Mol Diagn; 2002 Feb; 4(1):44-52. PubMed ID: 11826187
[TBL] [Abstract][Full Text] [Related]
14. Cytomorphological spectrum, including immunohistochemical results of 16 cases of clear cell sarcoma of soft tissue, along with positive EWSR1 gene rearrangement result in two cases.
Rao V; Rekhi B
Cytopathology; 2020 Jul; 31(4):280-287. PubMed ID: 32356379
[TBL] [Abstract][Full Text] [Related]
15. BRAF, KIT and NRAS mutations and expression of c-KIT, phosphorylated extracellular signal-regulated kinase and phosphorylated AKT in Japanese melanoma patients.
Oyama S; Funasaka Y; Watanabe A; Takizawa T; Kawana S; Saeki H
J Dermatol; 2015 May; 42(5):477-84. PubMed ID: 25766129
[TBL] [Abstract][Full Text] [Related]
16. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
[TBL] [Abstract][Full Text] [Related]
17. Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
Hou JY; Baptiste C; Hombalegowda RB; Tergas AI; Feldman R; Jones NL; Chatterjee-Paer S; Bus-Kwolfski A; Wright JD; Burke WM
Cancer; 2017 Apr; 123(8):1333-1344. PubMed ID: 28026870
[TBL] [Abstract][Full Text] [Related]
18. Dual-color, break-apart fluorescence in situ hybridization probe for distinguishing clear cell sarcoma of soft tissue from malignant melanoma.
Yoon JH; Baek YS; Jeon J; Oh CH; Song HJ
Int J Dermatol; 2014 Dec; 53(12):1464-7. PubMed ID: 25312298
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma.
Moltara ME; Novakovic S; Boc M; Bucic M; Rebersek M; Zadnik V; Ocvirk J
Radiol Oncol; 2018 Apr; 52(3):289-295. PubMed ID: 30210039
[TBL] [Abstract][Full Text] [Related]
20. Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma.
Negri T; Brich S; Conca E; Bozzi F; Orsenigo M; Stacchiotti S; Alberghini M; Mauro V; Gronchi A; Dusio GF; Pelosi G; Picci P; Casali PG; Pierotti MA; Pilotti S
Genes Chromosomes Cancer; 2012 Feb; 51(2):111-26. PubMed ID: 22045652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
